Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Over the past six months, Moderna’s shares (currently trading at $25.79) have posted a disappointing 19.2% loss, well below ...

We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed.

Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...

Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

When HHS secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...